Presence and distribution of 14-3-3 proteins in human ocular surface tissues

Molecular Vision

Volumn 14, Issue , 2008, Pages 2604-2615

  Shankardas, Jwalitha ^a   Senchyna, Michelle ^b   Dimitrijevich, Slobodan D ^a  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

^b ALCON RESEARCH LTD   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISOPROTEIN; PROTEIN 14 3 3; PROTEIN 14 3 3 BETA; PROTEIN 14 3 3 EPSILON; PROTEIN 14 3 3 ETA; PROTEIN 14 3 3 GAMMA; PROTEIN 14 3 3 THETA; PROTEIN 14 3 3 ZETA; STRATIFIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL LINE; CELL SPECIFICITY; CELL SURFACE; CONJUNCTIVA EPITHELIUM; CONTROLLED STUDY; CORNEA ENDOTHELIUM; CORNEA EPITHELIUM; CULTURE MEDIUM; ENDOTHELIUM CELL; EPITHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; LACRIMAL FLUID; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SECRETION; REGULATORY MECHANISM; WESTERN BLOTTING;

14-3-3 PROTEINS; BLOTTING, WESTERN; CELL EXTRACTS; CELLS, CULTURED; CONJUNCTIVA; CORNEA; CULTURE MEDIA, CONDITIONED; EPITHELIAL CELLS; EYE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; PROTEIN ISOFORMS; TEARS;

EID: 58149358990     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Kjarland E, Keen TJ, Kleppe R. Does isoform diversity explain functional differences in the 14-3-3 protein family? Curr Pharm Biotechnol 2006; 7:217-23.
2. Muslin AJ, Xing H. 14-3-3 proteins: regulation of subcellular localization by molecular interference. Cell Signal 2000; 12:703-9.
3. Dougherty MK, Morrison DK. Unlocking the code of 14-3-3. J Cell Sci 2004; 117:1875-84.
4. Mhawech P. 14-3-3 proteins-an update. Cell Res 2005; 15:228-36.
5. Aitken A. 14-3-3 proteins: a historic overview. Semin Cancer Biol 2006; 16:162-72.
6. Henriksson ML, Francis MS, Peden A, Aili M, Stefansson K, Palmer R, Aitken A, Hallberg B. A nonphosphorylated 14-3-3 binding motif on exoenzyme S that is functional in vivo. Eur J Biochem 2002; 269:4921-9.
7. Zhai J, Lin H, Shamim M, Schlaepfer WW, Canete-Soler R. Identification of a novel interaction of 14-3-3 with p190 Rho GEF. J Biol Chem 2001; 276:41318-24.
8. Petosa C, Masters SC, Bankston LA, Pohl J, Wang B, Fu H, Liddington RC. 14-3-3 zeta binds a phosphorylated Raf peptide and an unphosphorylated peptide via its conserved amphipathic groove. J Biol Chem 1998; 273:16305-10.
9. Masters SC, Pederson KJ, Zhang L, Barbieri JT, Fu H. Interaction of 14-3-3 with a nonphosphorylated protein ligand, exoenzyme S of Pseudomonas aeruginosa. Biochemistry 1999; 38:5216-21.
10. Zhang L, Wang H, Masters SC, Wang B, Barbieri JT, Fu H. Residues of 14-3-3 zeta required for activation of exoenzyme S of Pseudomonas aeruginosa. Biochemistry 1999; 38:12159-64.
11. Hermeking H, Benzinger A. 14-3-3 proteins in cell cycle regulation. Semin Cancer Biol 2006; 16:183-92.
12. van Heusden GP. 14-3-3 proteins: regulators of numerous eukaryotic proteins. IUBMB Life 2005; 57:623-9.
13. Ghahary A, Karimi-Busheri F, Marcoux Y, Li Y, Tredget EE, Taghi Kilani R, Li L, Zheng J, Karami A, Keller BO, Weinfeld M. Keratinocyte-releasable stratifin functions as a potent collagenase-stimulating factor in fibroblasts. J Invest Dermatol 2004; 122:1188-97.
14. Lam E, Kilani RT, Li Y, Tredget EE, Ghahary A. Stratifin-induced matrix metalloproteinase-1 in fibroblast is mediated by c-fos and p38 mitogen-activated protein kinase activation. J Invest Dermatol 2005; 125:230-8.
15. Ghahary A, Marcoux Y, Karimi-Busheri F, Li Y, Tredget EE, Kilani RT, Lam E, Weinfeld M. Differentiated keratinocyte-releasable stratifin (14-3-3 sigma) stimulates MMP-1 expression in dermal fibroblasts. J Invest Dermatol 2005; 124:170-7.
16. Ghaffari A, Li Y, Karami A, Ghaffari M, Tredget EE, Ghahary A. Fibroblast extracellular matrix gene expression in response to keratinocyte-releasable stratifin. J Cell Biochem 2006; 98:383-93.
17. Kilani RT, Guilbert L, Lin X, Ghahary A. Keratinocyte conditioned medium abrogates the modulatory effects of IGF-1 and TGF-beta1 on collagenase expression in dermal fibroblasts. Wound Repair Regen 2007; 15:236-44.
18. Zanello SB, Nayak R, Zanello LP, Farthing-Nayak P. Identification and distribution of 14-3-3 sigma (stratifin) in the human cornea. Curr Eye Res 2006; 31:825-33.
19. Vercoutter-Edouart AS, Lemoine J, Le Bourhis X, Louis H, Boilly B, Nurcombe V, Revillion F, Peyrat JP, Hondermarck H. Proteomic analysis reveals that 14-3-3 sigma is down-regulated in human breast cancer cells. Cancer Res 2001; 61:76-80.
20. Moreira JM, Gromov P, Celis JE. Expression of the tumor suppressor protein 14-3-3 sigma is down-regulated in invasive transitional cell carcinomas of the urinary bladder undergoing epithelial-to-mesenchymal transition. Mol Cell Proteomics 2004; 3:410-9.
21. Cheng L, Pan CX, Zhang JT, Zhang S, Kinch MS, Li L, Baldridge LA, Wade C, Hu Z, Koch MO, Ulbright TM, Eble JN. Loss of 14-3-3 sigma in prostate cancer and its precursors. Clin Cancer Res 2004; 10:3064-8.
22. Uchida D, Begum NM, Almofti A, Kawamata H, Yoshida H, Sato M. Frequent downregulation of 14-3-3 sigma protein and hypermethylation of 14-3-3 sigma gene in salivary gland adenoid cystic carcinoma. Br J Cancer 2004; 91:1131-8.
23. Tzivion G, Gupta VS, Kaplun L, Balan V. 14-3-3 proteins as potential oncogenes. Semin Cancer Biol 2006; 16:203-13.
24. Toyooka K, Muratake T, Watanabe H, Hayashi S, Ichikawa T, Usui H, Washiyama K, Kumanishi T, Takahashi Y. Isolation and structure of the mouse 14-3-3 eta chain gene and the distribution of 14-3-3 eta mRNA in the mouse brain. Brain Res Mol Brain Res 2002; 100:13-20.
25. Li Q, Lu Q, Estepa G, Verma IM. Identification of 14-3-3sigma mutation causing cutaneous abnormality in repeated-epilation mutant mouse. Proc Natl Acad Sci USA 2005; 102:15977-82.
26. Herron BJ, Liddell RA, Parker A, Grant S, Kinne J, Fisher JK, Siracusa LD. A mutation in stratifin is responsible for the repeated epilation (Er) phenotype in mice. Nat Genet 2005; 37:1210-2.
27. Moore JE, McMullen CB, Mahon G, Adamis AP. The corneal epithelial stem cell. DNA Cell Biol 2002; 21:443-51.
28. Pellegrini G, Dellambra E, Golisano O, Martinelli E, Fantozzi I, Bondanza S, Ponzin D, McKeon F, De Luca M. p63 identifies keratinocyte stem cells. Proc Natl Acad Sci USA 2001; 98:3156-61.
29. Dimitrijevich SD, Reese TJ, Gracy RW, Oakford LX, Howe WE. A Transmission Electron Microscopic Study of Methods for Harvesting Epithelial Cells from Human Corneal Tissue. In, Bailey, GW and Hall EL eds., Proceedings: Electron Microscopy Soc. of America, 49th Ann. Meeting 1991, p174, San Francisco Press, San Francisco.
30. Dimitrijevich SD, Reese TJ, Gracy RW, Wordinger R. FGF (a,b) in the human cornea and the epithelial tissue equivalent. Invest Ophthalmol Vis Sci 1993; 34:1315.
31. Dimitrijevich SD, Gracy R.W. Non-Contracting Tissue Equivalents (Skin, Cornea and Conjunctiva), (US Pat. 6,471,958, October, 2002).
32. Offord EA, Sharif NA, Mace K, Tromvoukis Y, Spillare EA, Avanti O, Howe WE, Pfeifer AM. Immortalized human corneal epithelial cells for ocular toxicity and inflammation studies. Invest Ophthalmol Vis Sci 1999; 40:1091-101.
33. Wilson SE, Weng J, Blair S, He YG, Lloyd S. Expression of E6/E7 or SV40 large T antigen-coding oncogenes in human corneal endothelial cells indicates regulated high-proliferative capacity. Invest Ophthalmol Vis Sci 1995; 36:32-40.
34. Dimitrijevich SD, Reese TJ, Yorio T, Gracy RW. In vitro model of the human corneal endothelium. Invest Ophthalmol Vis Sci 1994; 35:1602.
35. Argueso P, Balaram M, Spurr-Michaud S, Keutmann HT, Dana MR, Gipson IK. Decreased levels of the goblet cell mucin MUC5AC in tears of patients with Sjogren syndrome. Invest Ophthalmol Vis Sci 2002; 43:1004-11.
36. Spurr-Michaud S, Argueso P, Gipson I. Assay of mucins in human tear fluid. Exp Eye Res 2007; 84:939-50.
37. Dimitrijevich SD, Reese TJ, Yorio T, Gracy RW. An in vitro model of the human cornea. Invest Ophthalmol Vis Sci 1995; 36:S701.
38. Ward SL, Walker TL, Dimitrijevich SD. Evaluation of Chemically-Induced Toxicity Using an In Vitro Model of Human Corneal Epithelium. Toxicol In Vitro 1997; 11:121-39.
39. Gamache DA, Dimitrijevich SD, Weimer LK, Lang LS, Spellman JM, Graff G, Yanni JM. Secretion of proinflammatory cytokines by human conjunctival epithelial cells. Ocul Immunol Inflamm 1997; 5:117-28.
40. Matic M, Petrov IN, Chen S, Wang C, Dimitrijevich SD, Wolosin JM. Stem cells of the corneal epithelium lack connexins and metabolite transfer capacity. Differentiation 1997; 61:251-60.
41. Dellambra E, Golisano O, Bondanza S, Siviero E, Lacal P, Molinari M, D'Atri S, De Luca M. Downregulation of 14-3-3 sigma prevents clonal evolution and leads to immortalization of primary human keratinocytes. J Cell Biol 2000; 149:1117-30.
42. Kirschner M, Montazem A, Hilaire HS, Radu A. Long-term culture of human gingival keratinocyte progenitor cells by down-regulation of 14-3-3 sigma. Stem Cells Dev 2006; 15:556-65.
43. Shen J, Pavone A, Mikulec C, Hensley SC, Traner A, Chang TK, Person MD, Fischer SM. Protein expression profiles in the epidermis of cyclooxygenase-2 transgenic mice by 2- dimensional gel electrophoresis and mass spectrometry. J Proteome Res 2007; 6:273-86.
44. Akahira J, Sugihashi Y, Suzuki T, Ito K, Niikura H, Moriya T, Nitta M, Okamura H, Inoue S, Sasano H, Okamura K, Yaegashi N. Decreased expression of 14-3-3 sigma is associated with advanced disease in human epithelial ovarian cancer: its correlation with aberrant DNA methylation. Clin Cancer Res 2004; 10:2687-93.
45. Guweidhi A, Kleeff J, Giese N, El Fitori J, Ketterer K, Giese T, Buchler MW, Korc M, Friess H. Enhanced expression of 143-3sigma in pancreatic cancer and its role in cell cycle regulation and apoptosis. Carcinogenesis 2004; 25:1575-85.
46. Hermeking H. The 14-3-3 cancer connection. Nat Rev Cancer 2003; 3:931-43.
47. Ito Y, Miyoshi E, Uda E, Yoshida H, Uruno T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Matsuura N, Kakudo K, Kuma K, Miyauchi A. 14-3-3 sigma possibly plays a constitutive role in papillary carcinoma, but not in follicular tumor of the thyroid. Cancer Lett 2003; 200:161-6.
48. Seimiya H, Sawada H, Muramatsu Y, Shimizu M, Ohko K, Yamane K, Tsuruo T. Involvement of 14-3-3 proteins in nuclear localization of telomerase. EMBO J 2000; 19:2652-61.
49. Bonin LR, Madden K, Shera K, Ihle J, Matthews C, Aziz S, Perez-Reyes N, McDougall JK, Conroy SC. Generation and characterization of human smooth muscle cell lines derived from atherosclerotic plaque. Arterioscler Thromb Vasc Biol 1999; 19:575-87.
50. Yang Y, Spector A, Ma W, Wang RR, Larsen K, Kleiman NJ. The effect of catalase amplification on immortal lens epithelial cell lines. Exp Eye Res 1998; 67:647-56.
51. Dickson MA, Hahn WC, Ino Y, Ronfard V, Wu JY, Weinberg RA, Louis DN, Li FP, Rheinwald JG. Human keratinocytes that express hTERT and also bypass a p16(INK4a)-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics. Mol Cell Biol 2000; 20:1436-47.
52. Dimitrijevich SD, Boswell G, Ramirez RD, Shay JW. Telomerase Transfected Human Corneal Epithelial Cells as Components of Tissue Equivalents. Invest Ophthalmol Vis Sci 2001; 42:S268.
53. Jester JV, Huang J, Fisher S, Spiekerman J, Chang JH, Wright WE, Shay JW. Myofibroblast differentiation of normal human keratocytes and hTERT, extended-life human corneal fibroblasts. Invest Ophthalmol Vis Sci 2003; 44:1850-8.
54. Egan CA, Savre-Train I, Shay JW, Wilson SE, Bourne WM. Analysis of telomere lengths in human corneal endothelial cells from donors of different ages. Invest Ophthalmol Vis Sci 1998; 39:648-53.
55. Pereira-Faca SR, Kuick R, Puravs E, Zhang Q, Krasnoselsky AL, Phanstiel D, Qiu J, Misek DE, Hinderer R, Tammemagi M, Landi MT, Caporaso N, Pfeiffer R, Edelstein C, Goodman G, Barnett M, Thornquist M, Brenner D, Hanash SM. Identification of 14-3-3 theta as an antigen that induces a humoral response in lung cancer. Cancer Res 2007; 67:12000-6.
56. Martínez-Galán J, Torres B, Del Moral R, Muñoz-Gámez JA, Martín-Oliva D, Villalobos M, Núñez MI, Luna Jde D, Oliver FJ, Ruiz de Almodóvar JM. Quantitative detection of methylated ESR1 and 14-3-3-sigma gene promoters in serum as candidate biomarkers for diagnosis of breast cancer and evaluation of treatment efficacy. Cancer Biol Ther 2008; 7:958-65.
57. Chavez-Munoz C, Morse J, Kilani R, Ghahary A. Primary human keratinocytes externalize stratifin protein via exosomes. J Cell Biochem 2008; 104:2165-73.
58. Nagase H, Visse R, Murphy G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res 2006; 69:562-73.